Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)

L. Bergmann; F. Donskov; R. J. Motzer; E. Voog; E. J. Hovey; C. Gruellich; L. M. Nott; K. E. Cuff; T. Gil; N. Jensen V; C. Chevreau; S. Negrier; R. Depenbusch; I Cornelio; A. Champsaur; B. J. Escudier; S. K. Pal; T. Powles; T. K. Choueiri

Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)

L. Bergmann, F. Donskov, R. J. Motzer, E. Voog, E. J. Hovey, C. Gruellich, L. M. Nott, K. E. Cuff, T. Gil, N. Jensen V, C. Chevreau, S. Negrier, R. Depenbusch, I Cornelio, A. Champsaur, B. J. Escudier, S. K. Pal, T. Powles, T. K. Choueiri

KI, Onkologi

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

Originalsprog	Engelsk
Tidsskrift	Oncology Research and Treatment
Vol/bind	41
Udgave nummer	Suppl. 4
Sider (fra-til)	200-201
Antal sider	2
ISSN	2296-5270
Status	Udgivet - 2018
Begivenhed	Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie - Wien, Østrig Varighed: 28. sep. 2018 → 2. okt. 2018

Konference

Konference	Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie
Land	Østrig
By	Wien
Periode	28/09/2018 → 02/10/2018

Citationsformater

Bergmann, L., Donskov, F., Motzer, R. J., Voog, E., Hovey, E. J., Gruellich, C., Nott, L. M., Cuff, K. E., Gil, T., Jensen V, N., Chevreau, C., Negrier, S., Depenbusch, R., Cornelio, I., Champsaur, A., Escudier, B. J., Pal, S. K., Powles, T., & Choueiri, T. K. (2018). Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC). Oncology Research and Treatment, 41(Suppl. 4), 200-201.

Bergmann, L. ; Donskov, F. ; Motzer, R. J. ; Voog, E. ; Hovey, E. J. ; Gruellich, C. ; Nott, L. M. ; Cuff, K. E. ; Gil, T. ; Jensen V, N. ; Chevreau, C. ; Negrier, S. ; Depenbusch, R. ; Cornelio, I ; Champsaur, A. ; Escudier, B. J. ; Pal, S. K. ; Powles, T. ; Choueiri, T. K. / Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC). I: Oncology Research and Treatment. 2018 ; Bind 41, Nr. Suppl. 4. s. 200-201.

@article{9bdb229b38d5492cb7073038d4029ca8,

title = "Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)",

author = "L. Bergmann and F. Donskov and Motzer, {R. J.} and E. Voog and Hovey, {E. J.} and C. Gruellich and Nott, {L. M.} and Cuff, {K. E.} and T. Gil and {Jensen V}, N. and C. Chevreau and S. Negrier and R. Depenbusch and I Cornelio and A. Champsaur and Escudier, {B. J.} and Pal, {S. K.} and T. Powles and Choueiri, {T. K.}",

year = "2018",

language = "English",

volume = "41",

pages = "200--201",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S. Karger AG",

number = "Suppl. 4",

note = "Jahrestagung der Deutschen, {\"O}sterreichischen und Schweizerischen Gesellschaften f{\"u}r H{\"a}matologie und Medizinische Onkologie ; Conference date: 28-09-2018 Through 02-10-2018",

}

Bergmann, L, Donskov, F, Motzer, RJ, Voog, E, Hovey, EJ, Gruellich, C, Nott, LM, Cuff, KE, Gil, T, Jensen V, N, Chevreau, C, Negrier, S, Depenbusch, R, Cornelio, I, Champsaur, A, Escudier, BJ, Pal, SK, Powles, T & Choueiri, TK 2018, 'Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)', Oncology Research and Treatment, bind 41, nr. Suppl. 4, s. 200-201.

Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC). / Bergmann, L.; Donskov, F.; Motzer, R. J.; Voog, E.; Hovey, E. J.; Gruellich, C.; Nott, L. M.; Cuff, K. E.; Gil, T.; Jensen V, N.; Chevreau, C.; Negrier, S.; Depenbusch, R.; Cornelio, I; Champsaur, A.; Escudier, B. J.; Pal, S. K.; Powles, T.; Choueiri, T. K.

I: Oncology Research and Treatment, Bind 41, Nr. Suppl. 4, 2018, s. 200-201.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

TY - ABST

T1 - Outcomes based on age in the phase 3 Meteor trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)

AU - Bergmann, L.

AU - Donskov, F.

AU - Motzer, R. J.

AU - Voog, E.

AU - Hovey, E. J.

AU - Gruellich, C.

AU - Nott, L. M.

AU - Cuff, K. E.

AU - Gil, T.

AU - Jensen V, N.

AU - Chevreau, C.

AU - Negrier, S.

AU - Depenbusch, R.

AU - Cornelio, I

AU - Champsaur, A.

AU - Escudier, B. J.

AU - Pal, S. K.

AU - Powles, T.

AU - Choueiri, T. K.

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

VL - 41

SP - 200

EP - 201

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

SN - 2296-5270

IS - Suppl. 4

T2 - Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie

Y2 - 28 September 2018 through 2 October 2018

ER -